Alerts will be sent to your verified email
Verify EmailRAMAVISION
Rama Vision
|
Amrapali Industries
|
Biogen Pharmachem
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
6.61 % | 2.68 % | 0.21 % |
5yr average Equity Multiplier
|
1.69 | 5.43 | 1.01 |
5yr Average Asset Turnover Ratio
|
1.86 | 152.48 | 0.02 |
5yr Avg Net Profit Margin
|
1.98 % | 0.0 | -19.83 % |
Price to Book
|
2.63 | 2.42 | 0.88 |
P/E
|
29.95 | 45.12 | 66.97 |
5yr Avg Cash Conversion Cycle
|
69.81 Days | 0.2 Days | 0.0 |
Inventory Days
|
77.95 Days | 0.28 Days | 0.0 |
Days Receivable
|
19.66 Days | 0.0 | 0.0 |
Days Payable
|
6.81 Days | 0.3 Days | 1109.22 Days |
5yr Average Interest Coverage Ratio
|
4.22 | 1.17 | 902.8 |
5yr Avg ROCE
|
11.41 % | 21.59 % | 0.21 % |
5yr Avg Operating Profit Margin
|
4.78 % | 0.02 % | -19.88 % |
5 yr average Debt to Equity
|
0.43 | 2.08 | 0.0 |
5yr CAGR Net Profit
|
143.01 % | 14.37 % | n/a |
5yr Average Return on Assets
|
3.69 % | 0.61 % | 0.21 % |
Shareholdings
|
|||
Promoter Holding
|
54.22 % | 73.43 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
1.84 % | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Rama Vision
|
Amrapali Industries
|
Biogen Pharmachem
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|